Baxter Program Partner Parenteral manufacturing can be a complicated process. Cytotoxics, Antibody-Drug Conjugates(ADCs), highly potent compounds, biologics, and lyophilized products present many challenges and require specialized understanding and expertise. BioPharma Solutions brings longevity of experience in handling complex sterile manufacturing challenges. www.baxter.com Read more...
BSP Program Partner BSP Pharmaceuticals is a Contract Development and Manufacturing Organization fully dedicated to antineoplastic drugs, designed to handle the complexity of biopharmaceutical products and offering customized services to support its client from development to commercial manufacturing of injectables and oral formulations. www.bsppharmaceuticals.com Read more...
Catalent Program Partner From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. Catalent. More products. Better treatments. Reliably supplied.™ www.catalent.com
Concortis Program Partner Concortis is a start-up biotechnology company focusing on development of next generation antibody-drug-conjugate (ADC) technologies. Concortis has a headquarter in San Diego of California with operations in both US and China. www.concortis.com Read more...
CytomX Program Partner The universe of tumor specific ADC target antigens is limited. Cytomx Therapeutics’ Probody Drug Conjugates (PDCs) can target broadly expressed antigens selectively in the tumor microenvironment, increasing therapeutic window. PDCs therefore unlock new areas of target space for this emerging therapeutic modality. www.cytomx.com
Evonik Industries Program Partner Evonik Industries, a global leader in specialty chemicals, provides a broad range of products and services for the pharmaceutical industry, including custom API and drug product manufacturing, formulation development, and functional pharmaceutical polymers for parenteral and oral drug formulations. www.evonik.com Read more...
Fujifilm Diosynth Biotechnologies Exhibitor Fujifilm Diosynth Biotechnologies is one of the world’s leading providers of contract process development and manufacturing services for the biopharmaceutical industry, with over 800 employees operating from two sites in Billingham, UK and Research Triangle Park, North Carolina, USA. www.fujifilmdiosynth.com Read more...
Glykos Program Partner Glykos is a glycotechnology company working with some of the largest pharmaceutical companies in the world. Glykos focuses on three key areas: (1) Antibody-drug conjugation technologies, (2) development of novel antibodies against cancer and cancer stem cells and (3) stem cell glycomics. www.glykos.fi Read more...
Igenica Program Partner Igenica is harnessing the natural tumor microenvironment to deliver a pipeline of high-impact antibody-based cancer therapeutics. Using a complete suite of complementary and integrated technologies, Igenica discovers targets expressed on patient tumors, selects antibodies generated in the context of the disease and has the ability to deploy them as unmodified, site-specific antibody-drug conjugates (ADCs). www.igenica.com Read more...
Innate Pharma Program Partner Innate Pharma is a biopharmaceutical company developing first-in-class immunotherapy drugs for cancer and inflammatory diseases. The Company specializes in the development of new monoclonal antibodies targeting pathways controlling innate immunity with either immuno-stimulating properties in cancer or with immuno-blocking properties in inflammatory conditions. www.innate-pharma.com Read more...
Lonza Program Partner For over 25 years, Lonza has been helping emerging biotech and pharmaceutical companies improve and advance their products. Whether you are in the early stages of clinical development or providing commercial product to patients around the globe, Lonza supplies complete development services. www.lonza.com Read more...
Mersana Program Partner Utilizing its proprietary conjugation technology, which is comprised of the Fleximer® polymer, a variety of proprietary payloads and a broad array of customizable linker chemistries, Mersana is developing its next-generation antibody-drug conjugate platform with superior properties not found with other ADC technologies. Mersana is currently working with Pharma and Biotech companies to develop next generation Fleximer-ADCs. www.mersana.com
Pierre Fabre Exhibitor www.pierre-fabre.com
Piramal Healthcare Program Partner Piramal Healthcare’s Antibody Drug Conjugate Business is one of the world’s leading contract developmentand manufacturing teams delivering early phase clinical and late phase commercial supplies. Our flexiblemanufacturing regime and dedication to ADC processing is why our clients choose Piramal Healthcareas their preferred partner. www.piramalpharmasolutions.com Read more...
Polytherics Program Partner PolyTherics is a UK biotech company providing technology solutions enabling development of better biopharmaceuticals. PolyTherics has offers proprietary site-specific conjugation technologies for half-life extension of protein therapeutics, the creation of bispecific products and the efficient production of stable, homogeneous antibody-drug conjugates. www.polytherics.com Read more...
Quanta BioDesign Program Partner Quanta BioDesign, Ltd. was founded for the purpose of developing a line of products involved in drug discovery and diagnostic development. Over the past 30 years the PEGylation of biologics has been completely defined by the use of generally high MW and highly polydispersed PEGs. www.quantabiodesign.com Read more...
SAFC Program Partner SAFC is a leading contract manufacturer for the pharmaceutical and biopharmaceutical industry, specialized in high-value complex technologies including virus manufacturing, high potent APIs, potent fermentation and antibody drug conjugates. www.safcglobal.com Read more...
Sutro Biopharma Program Partner Sutro Biopharma, located in South San Francisco, is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies. www.sutrobio.com Read more...
SynAffix Conference Partner SynAffix is a life sciences company based in Nijmegen, The Netherlands. SynAffix’ proprietary site-specific bioconjugation platform involves the (post-recombinant) introduction of a specific tag into a protein of interest, to enable the smooth and irreversible attachment of a functionality of interest through a metal-free click reaction. www.synaffix.com Read more...